What is the share price of Hikal Ltd (HIKAL) today?
The share price of HIKAL as on 13th June 2025 is ₹375.80. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Hikal Ltd (HIKAL) share?
The past returns of Hikal Ltd (HIKAL) share are- Past 1 week: 0.74%
- Past 1 month: -5.39%
- Past 3 months: -2.10%
- Past 6 months: -7.40%
- Past 1 year: 24.83%
- Past 3 years: 48.13%
- Past 5 years: 223.69%
What are the peers or stocks similar to Hikal Ltd (HIKAL)?
The peers or stocks similar to Hikal Ltd (HIKAL) include:What is the dividend yield % of Hikal Ltd (HIKAL) share?
The current dividend yield of Hikal Ltd (HIKAL) is 0.37.What is the market cap of Hikal Ltd (HIKAL) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Hikal Ltd (HIKAL) is ₹4627.52 Cr as of 13th June 2025.What is the 52 week high and low of Hikal Ltd (HIKAL) share?
The 52-week high of Hikal Ltd (HIKAL) is ₹464.75 and the 52-week low is ₹294.30.What is the PE and PB ratio of Hikal Ltd (HIKAL) stock?
The P/E (price-to-earnings) ratio of Hikal Ltd (HIKAL) is 50.96. The P/B (price-to-book) ratio is 3.90.Which sector does Hikal Ltd (HIKAL) belong to?
Hikal Ltd (HIKAL) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Hikal Ltd (HIKAL) shares?
You can directly buy Hikal Ltd (HIKAL) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Hikal Ltd
HIKAL Share Price
375.800.88% (-3.35)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
HIKAL Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
HIKAL Performance & Key Metrics
HIKAL Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 50.96 | 3.90 | 0.37% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.21 | 6.66 | 0.83% |
100%
Analysts have suggested that investors can buy this stock
from 1 analyst
Price Upside
Earnings Growth
Rev. Growth
HIKAL Company Profile
Hikal Limited is engaged in the manufacturing of various chemical intermediates, specialty chemicals, active pharmaceutical ingredients and contract research activities. The Company offers pharmaceuticals and agrochemicals.
SUNPHARMA
PE Ratio
37.00
37.00
1Y Return
11.72%
11.72%
Buy Reco %
87.88
87.88
CIPLA
PE Ratio
23.03
23.03
1Y Return
2.38%
2.38%
Buy Reco %
74.19
74.19
DRREDDY
PE Ratio
20.02
20.02
1Y Return
11.76%
11.76%
Buy Reco %
56.67
56.67
TORNTPHARM
PE Ratio
57.53
57.53
1Y Return
13.13%
13.13%
Buy Reco %
72.00
72.00
MANKIND
PE Ratio
49.29
49.29
1Y Return
6.30%
6.30%
Buy Reco %
81.25
81.25
HIKAL Sentiment Analysis
HIKAL Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
HIKAL Stock Summary · May 2025
Hikal Limited demonstrated robust financial performance in Q4 FY '25, with significant EBITDA growth driven by strategic initiatives in the Pharma and CDMO sectors, despite facing competitive pressures in Crop Protection. The company is poised for a gradual recovery in this segment, supported by a commitment to operational efficiency and digitalization. While navigating uncertainties related to U.S. tariffs and increased operational costs, Hikal is enhancing its product portfolio and investing in high-potency chemistry to capitalize on emerging market opportunities. The Animal Health Division is also set for growth, bolstered by strategic partnerships and a focus on innovation. Overall, management's proactive approach to regulatory compliance and market dynamics positions the company favorably for sustainable growth in the coming years.
HIKAL Stock Growth Drivers
HIKAL Stock Growth Drivers
6Strong Financial Performance
Hikal Limited has reported significant financial achievements, including Q4 FY '25 revenue of INR 552
Growth in API and CDMO Segments
The API business has shown growth driven by increased volumes and new molecule offtake, with
HIKAL Stock Challenges
HIKAL Stock Challenges
6Stagnant Revenue and Profit Decline
The company has reported a significant decline in Profit After Tax (PAT), with current figures
Flat Growth in Crop Protection Business
The Crop Protection business is expected to experience muted growth, remaining flat compared to the
HIKAL Forecast
HIKAL Forecasts
Price
Revenue
Earnings
HIKAL Share Price Forecast
HIKAL Share Price Forecast
2025
Current
₹375.80
Baseline
Forecast for Jun 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹375.80
Baseline
Forecast for Jun 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
HIKAL Company Revenue Forecast
HIKAL Company Revenue Forecast
2025
Current
₹1.86
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2025
Current
₹1.86
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
HIKAL Stock EPS (Earnings Per Share) Forecast
HIKAL Stock EPS (Earnings Per Share) Forecast
2025
Current
₹7.36
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹7.36
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
HIKAL
HIKAL
Income
Balance Sheet
Cash Flow
Annual Normal View
HIKAL Income Statement
HIKAL Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,017.38 | 1,300.55 | 1,591.87 | 1,510.96 | 1,725.42 | 1,947.61 | 2,028.44 | 1,787.05 | 1,864.80 | 1,864.80 | ||||||||||
Raw Materials | 494.83 | 715.32 | 868.80 | 781.90 | 906.71 | 1,032.21 | 1,121.59 | 805.15 | 1,531.40 | 1,531.40 | ||||||||||
| Power & Fuel Cost | 85.63 | 108.41 | 132.04 | 129.99 | 147.83 | 175.46 | 186.91 | 170.16 | ||||||||||||
| Employee Cost | 116.69 | 128.06 | 135.69 | 156.57 | 164.32 | 203.38 | 222.44 | 246.53 | ||||||||||||
| Selling & Administrative Expenses | 43.74 | 45.90 | 52.50 | 55.57 | 64.05 | 95.21 | 107.96 | 113.59 | ||||||||||||
| Operating & Other expenses | 78.80 | 56.67 | 102.46 | 125.48 | 114.64 | 95.91 | 127.06 | 182.14 | ||||||||||||
EBITDA | 197.69 | 246.19 | 300.38 | 261.45 | 327.87 | 345.44 | 262.48 | 269.48 | 333.40 | 333.40 | ||||||||||
| Depreciation/Amortization | 69.14 | 85.59 | 92.88 | 82.46 | 85.25 | 95.67 | 109.01 | 117.61 | 134.40 | 134.40 | ||||||||||
| PBIT | 128.55 | 160.60 | 207.50 | 178.99 | 242.62 | 249.77 | 153.47 | 151.87 | 199.00 | 199.00 | ||||||||||
| Interest & Other Items | 48.27 | 49.12 | 58.43 | 52.42 | 36.20 | 31.22 | 48.10 | 56.37 | 75.20 | 75.20 | ||||||||||
| PBT | 80.28 | 111.48 | 149.07 | 126.57 | 206.42 | 218.55 | 105.37 | 95.50 | 123.80 | 123.80 | ||||||||||
| Taxes & Other Items | 12.54 | 34.27 | 46.01 | 42.14 | 73.28 | 58.06 | 26.99 | 25.90 | 33.00 | 33.00 | ||||||||||
| Net Income | 67.74 | 77.21 | 103.06 | 84.43 | 133.14 | 160.49 | 78.38 | 69.60 | 90.80 | 90.80 | ||||||||||
| EPS | 5.49 | 6.26 | 8.36 | 6.85 | 10.80 | 13.02 | 6.36 | 5.64 | 7.36 | 7.36 | ||||||||||
| DPS | 0.80 | 0.80 | 1.20 | 1.20 | 2.00 | 1.60 | 1.20 | 1.20 | 1.40 | 1.20 | ||||||||||
| Payout ratio | 0.15 | 0.13 | 0.14 | 0.18 | 0.19 | 0.12 | 0.19 | 0.21 | 0.19 | 0.16 |
HIKAL Company Updates
FY 2025FY 2025
Investor Presentation
May 14PDF
Feb 4PDF
Nov 12PDF
HIKAL Stock Peers
HIKAL Past Performance & Peer Comparison
HIKAL Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Hikal Ltd | 50.96 | 3.90 | 0.37% |
| Sun Pharmaceutical Industries Ltd | 37.00 | 6.03 | 0.95% |
| Cipla Ltd | 23.03 | 4.53 | 1.06% |
| Dr Reddy's Laboratories Ltd | 20.02 | 4.01 | 0.59% |
HIKAL Stock Price Comparison
Compare HIKAL with any stock or ETFCompare HIKAL with any stock or ETF
HIKAL
HIKAL Holdings
HIKAL Shareholdings
HIKAL Promoter Holdings Trend
HIKAL Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
HIKAL Institutional Holdings Trend
HIKAL Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
HIKAL Shareholding Pattern
HIKAL Shareholding Pattern
HIKAL Shareholding History
HIKAL Shareholding History
Foreign Institutions
Mutual Funds Invested in HIKAL
Mutual Funds Invested in HIKAL
Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Hikal Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 2.6539% | Percentage of the fund’s portfolio invested in the stock 1.17% | Change in the portfolio weight of the stock over the last 3 months -0.23% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 39/64 (-6) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.1689% | Percentage of the fund’s portfolio invested in the stock 1.80% | Change in the portfolio weight of the stock over the last 3 months -0.14% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 27/32 (-5) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0926% | Percentage of the fund’s portfolio invested in the stock 0.18% | Change in the portfolio weight of the stock over the last 3 months -0.04% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 142/318 (-3) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing HIKAL stock
smallcases containing HIKAL stock
Looks like this stock is not in any smallcase yet.
HIKAL Events
HIKAL Events
HIKAL Dividend Trend
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.37%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹3.73 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
HIKAL Dividend Trend
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.37%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹3.73 every year
HIKAL Upcoming Dividends
HIKAL Upcoming Dividends
No upcoming dividends are available
HIKAL Past Dividends
HIKAL Past Dividends
Cash Dividend
Ex DateEx DateFeb 7, 2025
Interim
Interim | Div/Share: ₹0.60
Dividend/Share
₹0.60
Ex DateEx Date
Feb 7, 2025
Cash Dividend
Ex DateEx DateSep 4, 2024
Final
Final | Div/Share: ₹0.60
Dividend/Share
₹0.60
Ex DateEx Date
Sep 4, 2024
Cash Dividend
Ex DateEx DateFeb 20, 2024
Interim
Interim | Div/Share: ₹0.60
Dividend/Share
₹0.60
Ex DateEx Date
Feb 20, 2024
Cash Dividend
Ex DateEx DateSep 18, 2023
Final
Final | Div/Share: ₹0.60
Dividend/Share
₹0.60
Ex DateEx Date
Sep 18, 2023
Cash Dividend
Ex DateEx DateFeb 14, 2023
Interim
Interim | Div/Share: ₹0.60
Dividend/Share
₹0.60
Ex DateEx Date
Feb 14, 2023
HIKAL Stock News & Opinions
HIKAL Stock News & Opinions
Articles & Videos
Earnings
Hikal consolidated net profit rises 48.08% in the March 2025 quarter
Net profit of Hikal rose 48.08% to Rs 50.20 crore in the quarter ended March 2025 as against Rs 33.90 crore during the previous quarter ended March 2024. Sales rose 7.25% to Rs 550.00 crore in the quarter ended March 2025 as against Rs 512.80 crore during the previous quarter ended March 2024. For the full year,net profit rose 30.46% to Rs 90.80 crore in the year ended March 2025 as against Rs 69.60 crore during the previous year ended March 2024. Sales rose 4.23% to Rs 1843.50 crore in the year ended March 2025 as against Rs 1768.70 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales550.00512.80 7 1843.501768.70 4 OPM %22.4418.41 -17.8115.10 - PBDT106.0079.60 33 258.20213.10 21 PBT68.3047.30 44 123.8095.50 30 NP50.2033.90 48 90.8069.60 30 Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Hikal standalone net profit rises 48.82% in the March 2025 quarter
Net profit of Hikal rose 48.82% to Rs 50.30 crore in the quarter ended March 2025 as against Rs 33.80 crore during the previous quarter ended March 2024. Sales rose 7.25% to Rs 550.00 crore in the quarter ended March 2025 as against Rs 512.80 crore during the previous quarter ended March 2024. For the full year,net profit rose 30.79% to Rs 90.90 crore in the year ended March 2025 as against Rs 69.50 crore during the previous year ended March 2024. Sales rose 4.23% to Rs 1843.50 crore in the year ended March 2025 as against Rs 1768.70 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales550.00512.80 7 1843.501768.70 4 OPM %22.4518.39 -17.8215.09 - PBDT106.1079.50 33 258.30213.00 21 PBT68.4047.20 45 123.9095.40 30 NP50.3033.80 49 90.9069.50 31 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Board of Hikal approves change in directorate
The Board of Hikal at its meeting held on 14 May 2025 has approved redesignation of Sameer Hiremath (DIN: 00062129), Managing Director as Vice Chairman & Managing Director.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Board of Hikal recommends Final Dividend
Hikal announced that the Board of Directors of the Company at its meeting held on 14 May 2025, has recommended a Final Dividend of Rs.0.80 per share (i.e.40%), subject to the approval of the shareholders.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Hikal announces board meeting date
Hikal will hold a meeting of the Board of Directors of the Company on 14 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Hikal to convene board meeting
Hikal will hold a meeting of the Board of Directors of the Company on 14 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Hikal consolidated net profit rises 6.83% in the December 2024 quarter
Net profit of Hikal rose 6.83% to Rs 17.20 crore in the quarter ended December 2024 as against Rs 16.10 crore during the previous quarter ended December 2023. Sales rose 0.09% to Rs 438.90 crore in the quarter ended December 2024 as against Rs 438.50 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales438.90438.50 0 OPM %16.4314.75 - PBDT57.0050.60 13 PBT23.8021.60 10 NP17.2016.10 7 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Board of Hikal recommends Interim Dividend
Hikal announced that the Board of Directors of the Company at its meeting held on 04 February 2025, has recommended a Interim dividend of Rs.0.60 per share (i.e.30%), subject to the approval of the shareholders.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Hikal to hold board meeting
Hikal will hold a meeting of the Board of Directors of the Company on 4 February 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Hikal appoints Head - Information Technology
Hikal has appointed Pankaj Sharma has been appointed as a Senior Management Personnel of the Company in the capacity as Head - Information Technology with effect from today i.e. 26 December 2024.Powered by Capital Market - Live
5 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 2.34%, vs industry avg of 9.02%
Over the last 5 years, market share decreased from 0.73% to 0.47%
Over the last 5 years, net income has grown at a yearly rate of -7.55%, vs industry avg of 15.29%